Autoimmune Diseases
291
80
87
110
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
20 trials with published results (7%)
Research Maturity
110 completed trials (38% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.4%
7 terminated out of 291 trials
94.0%
+7.5% vs benchmark
6%
17 trials in Phase 3/4
18%
20 of 110 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 110 completed trials
Clinical Trials (291)
Deciphering the Genetic Architecture of Autoimmune Diseases
A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease)
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Gluten Reduction and Risk of Celiac Disease
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
Is a Diet Necessary When Corticosteroid Treatment is Prescribed?
Alternative Care in Patients With Auto-Immune Diseases
Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement
Cluster of Differentiation 19 (CD19)/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Refractory Autoimmune Diseases
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases
Clonal Hematopoiesis of Immunological Significance
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
Exploratory Clinical Study on the Safety of STR-P004
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
Clinical Study of AFN50 Injection in the Autoimmune Diseases